CALCITAT 25, SOLUTION FOR INFUSION AND INJECTION IN CATTLE.

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

CALCIUM GLUCONATE MONOHYDRATE, CALCIUM BOROGLUCONATE, CALCIUM HYDROXIDE, MAGNESIUM CHLORIDE HEXAHYDRATE

Available from:

aniMedica GmbH

ATC code:

QA12AA

INN (International Name):

CALCIUM GLUCONATE MONOHYDRATE, CALCIUM BOROGLUCONATE, CALCIUM HYDROXIDE, MAGNESIUM CHLORIDE HEXAHYDRATE

Dosage:

Unknown

Pharmaceutical form:

Solution for Inj/Inf

Prescription type:

LM-Licensed Merchant

Therapeutic group:

Bovine

Therapeutic area:

Calcium

Therapeutic indications:

Vitamins & Minerals

Authorization status:

Authorised

Authorization date:

1999-10-01

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Calcitat 25, solution for infusion and injection in cattle.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for infusion and injection.
A clear colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Bovine.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Paresis resulting from hypocalcaemia before, during and after parturition or during lactation. Downer cow syndrome.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances.
Do not use in animals suffering from hypercalcaemia, hyperparathyroidism, acidosis, severe kidney damage.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Caution must be exercised when this product is used intravenously. As intravenous administration of this product
could cause death, this route should only be used by a veterinary surgeon.
Each 100 ml of solution contains:
Active Substances
Calcium gluconate monohydrate
1.55 g
Calcium borogluconate
21.45 g
Calcium hydroxide
0.66 g
Magnesium Chloride hexahydrate
3.25 g
Excipients
Methyl Parahydroxybenzoate (E219)
0.10 g
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 17/01/2014_
_CRN 7016702_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Intravenous - administer slowly and at body temperature. Monitor cardiac performance during administration.
Subcutaneous - divide large volumes into several injection sites.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Rapid intravenous infusion may result in transient ca